Non-small Cell Lung Cancer Clinical Trials in Copenhagen
2 recruitingCopenhagen, Denmark
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Non-small Cell Lung Cancer
Bristol-Myers Squibb1,000 enrolled280 locationsNCT06561386
Recruiting
Copenhagen Master Observational Trial
Breast CancerNon-small Cell Lung Cancer
Rigshospitalet, Denmark2,400 enrolled1 locationNCT05145244